Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 86,727,396
- Total 13F shares
- 87,359,094
- Share change
- -2,896,716
- Total reported value
- $1,793,463,324
- Put/Call ratio
- 29%
- Price per share
- $20.53
- Number of holders
- 195
- Value change
- -$71,085,162
- Number of buys
- 111
- Number of sells
- 76
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
8.7%
|
7,552,431
|
$179,747,858 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.6%
|
7,436,616
|
$176,991,461 | — | 31 Mar 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
6.5%
|
5,660,000
|
$134,708,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
4,926,984
|
$117,262,219 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.6%
|
4,819,594
|
$114,706,337 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.9%
|
4,222,222
|
$100,488,884 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
3.6%
|
3,133,113
|
$74,568,089 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.8%
|
2,459,235
|
$58,530,000 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
2.8%
|
2,412,500
|
$57,417,500 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.4%
|
2,066,685
|
$49,187,103 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.3%
|
2,032,059
|
$48,363,005 | — | 31 Mar 2024 | |
| BVF INC/IL |
13F
|
Company |
2.2%
|
1,875,000
|
$44,625,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
1,815,758
|
$43,215,040 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
1,778,548
|
$42,335,205 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2%
|
1,749,000
|
$41,626,200 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
1,655,052
|
$39,390,237 | — | 31 Mar 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.9%
|
1,608,540
|
$38,283,252 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.8%
|
1,544,287
|
$36,754,031 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
1,495,705
|
$35,597,768 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
1,310,073
|
$31,179,737 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1.3%
|
1,100,988
|
$26,203,514 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.2%
|
1,045,032
|
$24,871,762 | — | 31 Mar 2024 | |
| Aisling Capital Management LP |
13F
|
Company |
1.2%
|
1,025,000
|
$24,395,000 | — | 31 Mar 2024 | |
| Iron Triangle Partners LP |
13F
|
Company |
1.1%
|
973,057
|
$23,158,757 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
900,000
|
$21,420,000 | — | 31 Mar 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1%
|
894,993
|
$21,300,833 | — | 31 Mar 2024 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
1%
|
875,000
|
$20,825,000 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.94%
|
812,964
|
$19,348,543 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.91%
|
785,644
|
$18,698,326 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.9%
|
784,811
|
$18,678,502 | — | 31 Mar 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.9%
|
780,000
|
$18,564,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
741,827
|
$17,655,482 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.85%
|
736,148
|
$17,520,322 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.83%
|
718,552
|
$17,101,538 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.79%
|
682,464
|
$16,242,643 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.79%
|
681,874
|
$16,228,601 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.76%
|
659,574
|
$15,697,861 | — | 31 Mar 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.76%
|
658,694
|
$15,676,917 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
635,207
|
$15,117,926 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.62%
|
538,714
|
$12,821,393 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.59%
|
514,852
|
$12,253,478 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.59%
|
511,501
|
$12,173,140 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.54%
|
465,259
|
$11,073,164 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.53%
|
455,852
|
$10,849,278 | — | 31 Mar 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.49%
|
425,673
|
$10,131,000 | — | 31 Mar 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.47%
|
405,193
|
$9,643,593 | — | 31 Mar 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.46%
|
397,997
|
$9,472,329 | — | 31 Mar 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.46%
|
396,878
|
$9,445,696 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
392,686
|
$9,345,926 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.43%
|
373,238
|
$8,883,064 | — | 31 Mar 2024 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q2 2024
As of 30 Jun 2024,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,359,094 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Kynam Capital Management, LP, VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Eversept Partners, LP, Avidity Partners Management LP, Point72 Asset Management, L.P., and Sofinnova Investments, Inc..
This page lists
195
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
188
Q2 2024 holders
195
Holder diff
7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.